Class III Antiarrhythmic Agents Have a Lot of Potential but a Long Way to Go

Reduced Effectiveness and Dangers of Reverse Use Dependence

  • Hondeghem, L. M. MD, PhD
  • Snyders, D. J. MD

  • Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, Tennessee.

Address for correspondence: Luc Hondeghem, MD, PhD, Medical Center North CC-2209, Department of Medicine, Vanderbilt University, Nashville, TN 37232.

L.M.H. is the Stahlman Professor of Cardiovascular Medicine.

Supported by the Stahlman endowment.

The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.

Circulation 81(2):p 886-690, February 1990.
Copyright © 1990 American Heart Association, Inc.
View full text|Download PDF